Verition Fund Management
LXRX icon

Verition Fund Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Verition Fund Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,158
Closed -$30.5K – 3396
2024
Q2 		$30.5K Buy
+18,158
New +$32.6K ﹤0.01% 2839
2023
Q4 		– Sell
-91,700
Closed -$100K – 2551
2023
Q3 		$100K Buy
91,700
+18,400
+25% +$32.3K ﹤0.01% 2120
2023
Q2 		$168K Buy
+73,300
New +$195K ﹤0.01% 1897
2014
Q1 		– Sell
-1,844
Closed -$23K – 590
2013
Q4 		$23K Buy
+1,844
New +$29.3K 0.01% 489

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return